DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY
· Real-Time Price · USD
13.90
0.03 (0.22%)
At close: Aug 15, 2025, 10:01 AM
DENTSPLY SIRONA Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.67B | 3.72B | 3.79B | 3.9B | 3.9B | 3.94B | 3.96B | 3.94B | 3.94B | 3.93B | 3.92B | 4.02B | 4.14B | 4.19B | 4.25B | 4.25B | 4.07B | 3.49B |
Cost of Revenue | 1.77B | 1.8B | 1.83B | 1.86B | 1.86B | 1.87B | 1.88B | 1.85B | 1.84B | 1.81B | 1.8B | 1.83B | 1.86B | 1.89B | 1.89B | 1.91B | 1.88B | 1.73B |
Gross Profit | 1.9B | 1.92B | 1.96B | 2.04B | 2.04B | 2.07B | 2.09B | 2.08B | 2.09B | 2.13B | 2.12B | 2.2B | 2.28B | 2.3B | 2.36B | 2.34B | 2.19B | 1.77B |
Operating Income | -797M | -858M | -879M | -297M | -71M | -41M | -29M | -147M | 149M | 188M | 227M | 426M | 525M | 561M | 622M | 603M | 525.7M | 266.4M |
Interest Income | n/a | n/a | n/a | n/a | 18M | 18M | 18M | 37M | 19M | 19M | 19M | n/a | n/a | 1M | 1M | 1M | 1.4M | 1.4M |
Pretax Income | -1.11B | -923M | -936M | -356M | -128M | -116M | -175M | -224M | -1.22B | -1.17B | -1.06B | -929M | 450M | 493M | 559M | 544M | 472.7M | 218.8M |
Net Income | -949M | -908M | -910M | -413M | -185M | -95M | -132M | -214M | -1.02B | -1.04B | -950M | -833M | 328M | 351M | 394M | 390.5M | 353.5M | 162.1M |
Selling & General & Admin | 1.49B | 1.55B | 1.6B | 1.63B | 1.61B | 1.62B | 1.62B | 1.61B | 1.64B | 1.63B | 1.59B | 1.56B | 1.55B | 1.54B | 1.55B | 1.6B | 1.55B | 1.43B |
Research & Development | 155M | 159M | 165M | 166M | 172M | 180M | 184M | 184M | 179M | 175M | 174M | 190M | 184M | 179M | 171M | 156M | 150M | 128M |
Other Expenses | 1.05B | 1.07B | 1.07B | 548M | 22M | 7M | 2M | 4M | 4M | n/a | 1M | 1M | 5M | 5M | 2M | 2M | -2M | -1M |
Operating Expenses | 2.69B | 2.78B | 2.84B | 2.34B | 1.8B | 1.81B | 1.8B | 1.79B | 1.81B | 1.8B | 1.76B | 1.75B | 1.74B | 1.72B | 1.72B | 1.71B | 1.62B | 1.46B |
Interest Expense | 74M | 70M | 69M | 76M | 76M | 81M | 83M | 79M | 75M | 68M | 60M | 53M | 53M | 54M | 56M | 58M | 58.5M | 56M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -2M | -2M | -2M | -2M | n/a | n/a | n/a | n/a | n/a | 500K | 500K | 500K |
Cost & Expenses | 4.47B | 4.58B | 4.67B | 4.21B | 3.66B | 3.67B | 3.68B | 3.65B | 3.66B | 3.61B | 3.56B | 3.58B | 3.6B | 3.61B | 3.61B | 3.62B | 3.5B | 3.19B |
Income Tax Expense | -162M | -15M | -26M | 54M | 53M | -24M | -43M | -5M | -185M | -128M | -105M | -92M | 107M | 124M | 138M | 126M | 103.5M | 44.5M |
Shares Outstanding (Basic) | 199.3M | 199.1M | 203.2M | 201M | 205.6M | 207.4M | 210M | 211.8M | 211.9M | 214.5M | 215.1M | 214.9M | 214.9M | 217.01M | 218M | 218.6M | 218.4M | 218.8M |
Shares Outstanding (Diluted) | 199.3M | 199.8M | 203.2M | 201M | 205.6M | 208.5M | 210.9M | 211.8M | 213.1M | 214.5M | 215.1M | 214.9M | 215.3M | 217.8M | 219.2M | 220.5M | 220.7M | 219.9M |
EPS (Basic) | -4.75 | -4.54 | -4.55 | -2.07 | -0.87 | -0.44 | -0.64 | -1.03 | -4.78 | -4.85 | -4.42 | -3.88 | 1.52 | 1.62 | 1.81 | 1.79 | 1.62 | 0.74 |
EPS (Diluted) | -4.75 | -4.54 | -4.55 | -2.07 | -0.87 | -0.45 | -0.65 | -1.04 | -4.79 | -4.85 | -4.42 | -3.88 | 1.51 | 1.60 | 1.79 | 1.77 | 1.61 | 0.74 |
EBITDA | -692M | -491M | -497M | 78M | 305M | 318M | 261M | 209M | -791M | -772M | -669M | -504M | 861M | 916M | 970M | 936.2M | 874.2M | 602.7M |
EBIT | -1.04B | -853M | -867M | -280M | -52M | -36M | -93M | -147M | -1.14B | -1.1B | -996M | -872M | 482M | 522M | 582M | 569.4M | 513.4M | 258.4M |
Depreciation & Amortization | 344M | 342M | 349M | 346M | 345M | 345M | 343M | 336M | 330M | 327M | 327M | 334M | 337M | 342M | 346M | 348.6M | 351.6M | 343.6M |